Keenova to Demonstrate Live Dupuytren's Contracture Treatment Procedure During American Association for Hand Surgery Meeting

The MarketWatch News Department was not involved in the creation of this content.-- This marks the first live procedure at AAHS, as well as a first for Keenova. -- Treatment takes ...
MarketWatch

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX(R) (collagenase clostridium histolyticum)

MALVERN, Pa., Nov. 20, 2024 /CNW/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his treatment ...
ABC News

Penis-Straightening Drug Xiaflex May Provide Relief for Peyronie's

Pfizer's new drug for claw hand may be used by men with bent phallus. Feb. 5, 2010— -- A new drug for claw hand, a condition that causes bent fingers, may serve double-duty as a ...
MM&M

Endo embarks on Steve’s Journey in branded Xiaflex campaign

Months after reupping its Dupuytren’s contracture awareness efforts with Pro Football Hall of Famer John Elway, Endo has launched its first branded TV commercial. Just over a week ago, the ...
Morningstar

Endo Announces Peyronie's Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association

MALVERN, Pa., March 12, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum, or ...
WGNO

Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)

MALVERN, Pa., Feb. 17, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its new branded television commercial, Steve's Journey. The campaign, featuring a real Dupuytren's ...
WKRG

Endo Announces Peyronie's Disease Presentation at the SurgeWest Annual Meeting of the Western Section of the American Urological Association

MALVERN, Pa., Oct. 25, 2024 /PRNewswire/ -- Endo, Inc. announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX ® (collagenase clostridium histolyticum, or CCH) in patients ...
pix11

John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)

MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ -- Endo, Inc. ("Endo") (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren's contracture patient journey, including his ...